Literature DB >> 17618031

Oxygen/glucose deprivation increases the integration of recombinant P2X7 receptors into the plasma membrane of HEK293 cells.

Doreen Milius1, Helke Gröger-Arndt, Doychin Stanchev, Christine Lange-Dohna, Steffen Rossner, Beata Sperlagh, Kerstin Wirkner, Peter Illes.   

Abstract

Recombinant human P2X(7) receptors, C-terminally labelled with enhanced green fluorescent protein (P2X(7)-EGFP), were transiently expressed in HEK293 cells. Activation of these receptors by their preferential agonist 2',3'-O-(4-benzoylbenzoyl)-ATP (BzATP) induced inward currents and propidium ion uptake indicating the opening of cationic channels and of large pores permeable for dye molecules, respectively. Two mutants of P2X(7) receptors (P2X(7)-EGFP-I568N, -E496A) representing polymorphisms in the P2X(7) gene known to interfere with normal receptor-trafficking and with optimal assembly of its subunits, responded with much lower current amplitudes to BzATP than their wild-type counterpart. Similarly, the normal propidium ion uptake induced by BzATP at the wild-type P2X(7) receptor was abolished by the two mutants. Confocal laser scanning microscopy indicated that in vitro ischemia of 12h duration increased the integration of P2X(7)-EGFP, but not of its two mutants, into the plasma membrane of HEK293 cells. Further, this ischemic stimulus facilitated the current response to BzATP in HEK293 cells permanently transfected with P2X(7) receptors. Finally, the fluorescence intensity per cell measured by flow cytometry and P2X(7) antibodies directed against an extracellular, but not an intracellular epitope of the receptor, were also increased. In conclusion, P2X(7) receptors may alter their trafficking properties during ischemia and thereby contribute to the ATP-induced damage of various cell-types including neurons.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17618031     DOI: 10.1016/j.tox.2007.05.028

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  9 in total

1.  P2X7 receptor activation mediates organic cation uptake into human myeloid leukaemic KG-1 cells.

Authors:  Safina Gadeock; Aleta Pupovac; Vanessa Sluyter; Mari Spildrejorde; Ronald Sluyter
Journal:  Purinergic Signal       Date:  2012-06-05       Impact factor: 3.765

2.  P2 receptors in renal pathophysiology.

Authors:  Clare M Turner; James I Elliott; Frederick W K Tam
Journal:  Purinergic Signal       Date:  2009-06-09       Impact factor: 3.765

Review 3.  Neuronal P2X7 Receptors Revisited: Do They Really Exist?

Authors:  Peter Illes; Tahir Muhammad Khan; Patrizia Rubini
Journal:  J Neurosci       Date:  2017-07-26       Impact factor: 6.167

4.  N-terminal tagging of human P2X7 receptor disturbs calcium influx and dye uptake.

Authors:  Karin Dreisig; Nikolaj Pagh Kristensen; Maja Wallentin Dommer; Niklas Rye Jørgensen; Birgitte Rahbek Kornum
Journal:  Purinergic Signal       Date:  2017-12-30       Impact factor: 3.765

5.  P2X(7) receptor at the heart of disease.

Authors:  Ei Vasileiou; R M Montero; C M Turner; G Vergoulas
Journal:  Hippokratia       Date:  2010-07       Impact factor: 0.471

Review 6.  Pathophysiology of astroglial purinergic signalling.

Authors:  Heike Franke; Alexei Verkhratsky; Geoffrey Burnstock; Peter Illes
Journal:  Purinergic Signal       Date:  2012-05-01       Impact factor: 3.765

7.  Peripheral myelin protein 22 modulates store-operated calcium channel activity, providing insights into Charcot-Marie-Tooth disease etiology.

Authors:  Carlos G Vanoye; Masayoshi Sakakura; Rose M Follis; Alexandra J Trevisan; Malathi Narayan; Jun Li; Charles R Sanders; Bruce D Carter
Journal:  J Biol Chem       Date:  2019-06-18       Impact factor: 5.157

8.  Effects of acute perinatal asphyxia in the rat hippocampus.

Authors:  Juliana Karl Frizzo; Michele Petter Cardoso; Adriano Martimbianco de Assis; Marcos Luiz Perry; Cinzia Volonté; Marcos Emílio Frizzo
Journal:  Cell Mol Neurobiol       Date:  2010-01-23       Impact factor: 5.046

9.  Purinergic signaling in inflammatory renal disease.

Authors:  Nishkantha Arulkumaran; Clare M Turner; Marije L Sixma; Mervyn Singer; Robert Unwin; Frederick W K Tam
Journal:  Front Physiol       Date:  2013-07-29       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.